Skip to content

ONC

BeOne Medicines Ltd.

NASDAQ · Healthcare · Medical - Pharmaceuticals · US

$370.17
+0.30%
Ask drillr
0
Insider buys (3m)
54
Insider sells (3m)
-$124.8M
Net value (3m)
+19.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 15, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdM-Exempt31,027$37
Oct 15, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale7,167$350
Oct 15, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdM-Exempt403,351$2.84
Oct 15, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale5,681$351
Oct 15, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale10,361$350
Oct 15, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale6,558$353
Oct 15, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale1,260$353
Oct 2, 2026Lee Chan Henry · officer: SVP, General CounselSale1,115$375
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale14,525$367
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale160$357
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale2,241$361
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale3,499$363
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale738$367
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdM-Exempt403,364$2.84
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale3,419$364
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdM-Exempt31,028$37
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale4,239$362
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale2,047$366
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale120$359
Sep 30, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale40$359
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale1,181$345
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdM-Exempt403,351$2.84
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdM-Exempt31,027$37
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale6,278$351
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale7,492$348
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale1,517$347
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale1,721$348
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale6,569$350
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale2,841$346
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale10,688$349
Institutional positioning

13F filings over the trailing two quarters

New 82Increased 222Reduced 173Sold out 48
FilerActionSharesFiled
BAKER BROS. ADVISORS LPIncreased8,801,567Aug 14, 2026
BAKER BROS. ADVISORS LPUnchanged8,799,053May 15, 2026
PRIMECAP MANAGEMENT CO/CA/Increased5,007,931Aug 14, 2026
PRIMECAP MANAGEMENT CO/CA/Reduced4,975,181May 11, 2026
Capital International InvestorsIncreased4,210,221Aug 12, 2026
CAPITAL INTERNATIONAL INVESTORSReduced4,158,726May 13, 2026
FMR LLCReduced3,693,610May 15, 2026
FMR LLCReduced2,478,527Aug 13, 2026
Capital World InvestorsIncreased2,249,582Aug 12, 2026
CAPITAL WORLD INVESTORSNew Position1,622,687May 13, 2026
CITADEL ADVISORS LLCIncreased1,445,817Sep 2, 2026
CITADEL ADVISORS LLCIncreased1,052,498May 15, 2026
HHLR ADVISORS, LTD.Unchanged1,034,306May 15, 2026
TEMASEK HOLDINGS (PRIVATE) LTDReduced862,643May 12, 2026
Temasek Holdings (Private) LtdReduced845,729Aug 7, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 15, 2026